Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MDVN $105.33 8.3600 +8.62%
PBYI $90.60 6.4700 +7.69%
BDSI $8.15 0.5000 +6.54%
OGXI $3.45 0.2100 +6.48%
TKMR $10.83 0.5800 +5.66%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CTIX $2.57 -0.1400 -5.17%
SNSS $1.40 -0.0750 -5.10%
MNKD $4.29 -0.1700 -3.81%
TLOG $2.35 -0.0900 -3.69%
CCXI $8.24 -0.3000 -3.51%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

How to Avoid Overdiagnosis and Overtreatment of Breast Cancer

(Forbes) July 16, 2015 - One way a woman can avoid the reported risks of breast cancer over diagnosis is by not getting screened.
read article 



Highest Prescribers Of Cancer Drug Paid As Speakers

(Hartford Courant) July 17, 2015 - Top prescribers of narcotic used for cancer pain paid more than $870,000 in speaking fees by maker.
read article 



Physicians Testified for Tobacco Companies Against Plaintiffs With Head, Neck Cancers

(Stanford Medicine) July 17, 2015 - A small group of otolaryngologists hired by tobacco companies testified repeatedly that years of heavy smoking did not cause individual cancer cases, a new study reports.
read article 



System to Boost Levels of Resveratrol, Quercetin Could Provide New Options for Cancer Therapy

(Oregon State University) July 16, 2016 - Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential use of an existing chemotherapeutic cancer drug.
read press release 



Veterans Returning From Middle East Face Higher Skin Cancer Risk

(VICC) July 16, 2015 - Soldiers who served in the glaring desert sunlight of Iraq and Afghanistan returned home with an increased risk of skin cancer, due not only to the desert climate, but also a lack of sun protection, a Vanderbilt study reports.
read article 



Pneumonitis an Adverse Effect of PD-Inhibitor Immunotherapy

(Medscape Medical News) July 15, 2015 - Clinicians treating melanoma with programmed cell death (PD) inhibitors report autoimmune pneumonitis as a rare but potentially serious toxic effect.
read article (free registration required) 



Wilmot Scientists Aim at a Genetically Lethal Strain of Leukemia

(URMC) July 16, 2015 - Researchers at UR Medicine's Wilmot Cancer Institute have developed what they believe to be the first mouse model to investigate why a certain subset of acute myeloid leukemia (AML) patients responds particularly poorly to chemotherapy.
read article 



What's Next for Patients with Chemoresistant Follicular Lymphoma?

(Medscape Medical News) July 16, 2015 - Approximately 1 in 5 patients with follicular lymphoma (FL) relapse within 2 years despite the best rituximab-based therapies currently available. Is it possible to identify these patients early and how can they best be managed clinically?
read article (free registration required) 



Massey Researchers Find Link Between Cancer Gene and Obesity

(Massey/News Blog) July 16, 2015 - Virginia Commonwealth University Massey Cancer Center researchers have discovered that a gene known to cause cancer also may play a role in determining if someone becomes obese.
read article 



Here's the Amount of Exercise That Lowers Breast Cancer Risk

(TIME) July 16, 2015 - More than 100 studies have found that physical activity can lower breast cancer risk; the most active women tend to have a 25% lower chance of developing the disease than the least active women.
read article 



Amgen Reports Positive Preliminary Results on Leukemia Drug

(Reuters) July 16, 2015 - Amgen Inc on Thursday said some patients with a deadly form of leukemia experienced complete remission after being treated with its Blincyto drug in a midstage clinical trial, results that could eventually lead to an expanded approval of the pricy cancer medicine.
read article 



Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

(Morningstar) July 16, 2015 - Amgen today announced the top-line results of a Phase 2 open-label, single-arm, multicenter trial to evaluate the efficacy and safety of BLINCYTO® (blinatumomab) in adults with relapsed or refractory Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukemia (ALL).
read article 



Sanofi Federates to Fuel Drug Development and Growth

(PharmaTimes [UK]) July 16, 2015 - Sanofi has unveiled plans to carve up its operations into five global business units in the hope of maximising growth opportunities and optimising innovation and new drug development.
read article 



Running a Few Tests on Theranos: Can Elizabeth Holmes Revolutionize Diagnostics?

(Forbes) July 15, 2015 - Holmes's company, Theranos, promises to replace traditional blood tests with a cheaper, less painful alternative. But its technology remains shrouded in mystery, even controversy.
read article 



Pharma Boosts Support for Continuing Medical Education, But Only a Little

(Wall Street Journal/Pharmalot blog) July 15, 2015 - Over the past several years, drug and device makers have been under pressure to reduce their role in CME, which are programs that doctors are often required to attend to maintain their licenses.
read article (paid subscription required) 



Former CMS Chief to Become Top Lobbyist for Health Plans

(Washington Post) July 15, 2015 - Marilyn Tavenner — who led the rocky roll-out of HealthCare.gov — will become the head of America’s Health Insurance Plans (AHIP), the leading national trade group for health insurance, AHIP’s board of directors announced Wednesday.
read article (free registration required) 



Specialty Pharmacies Proliferate, Along With Questions

(New York Times) July 15, 2015 - Dispensaries for expensive drugs that treat complex or rare diseases are surging, but their customer service and business practices are under scrutiny.
read article 



For Families Impacted by Cancer, Pillow Talk May Help with Hard Conversations

(CancerCare) July 16, 2015 – In an effort to help many of the 1.2 million Americans who receive a cancer diagnosis each year deal with the significant emotional challenges of being told they have the disease, Bayer and CancerCare, a leading national cancer support organization, have officially launched Pillow Talk: Conversations about Cancer.
read press release 



Cancer Patients Start Protest Group Like ACT UP

(Medscape Medical News) July 15, 2015 - MET UP just formed in the last few months but already has a demonstration planned for the fall in Washington, DC.
read article (free registration required) 



After Dropping Beneficiary Linked to Planned Parenthood, Houses Passes Breast Cancer Research Bill

(Times-Picayune [New Orleans, LA]) July 15, 2015 - One day after the loss of Republican support forced House leaders to pull a bill funding breast cancer research, the bill was modified and passed easily on Wednesday (July 15).
read article 



AB Science Hit With FDA Warning Letter Over Clinical Trials

(Outsourcing Pharma) July 16, 2015 - France’s AB Science has received a warning letter from the US FDA for its failure to adhere to agency regulations and to protect trial subjects’ safety in a pancreatic cancer study and GIST (gastrointestinal stromal tumor) studies from 2009 to 2013.
read article 



Immunocore Raises $320 Million in Venture Funding

(Wall Street Journal) July 16, 2015 - Immunocore Ltd., a closely held U.K. biotech company, said it has raised $320 million in venture funding, in the latest sign of investor appetite for treatments that harness the immune system to fight cancer.
read article (paid subscription required) 



Cancer Patient Saw Costs Jump

(Charlotte Observer) July 15, 2015 - Jimmy White of Charlotte is an example of a cancer patient whose out-of-pocket bills jumped when he switched from injections to pills.
read article 



Carolinas Patients Pay More For Oral Chemo

(Charlotte Observer) July 15, 2015 - North Carolina is one of only 11 states where cancer patients who get their treatment in pill form pay much more than those who get chemotherapy by infusion or injection.
read article 



AB Science Announces Initiation of an Adaptive Design Phase 2/3 Study With Masitinib in Patients With Refractory Metastatic Ovarian Cancer

(TheStreet) July 15, 2015 - AB Science SA announces the initiation of a seamless adaptive design phase 2/3 study to evaluate the safety and efficacy of masitinib in combination with gemcitabine in patients with refractory advanced or metastatic epithelial ovarian cancer.
read article